Latest News

STAT Plus: A former Taro Pharma executive is indicted in generic price-fixing probe

A former senior executive at Taro Pharmaceuticals USA was indicted for his role in a wide-ranging conspiracy to fix prices for generic drugs, the third time that a high-ranking drug company official has been charged since federal authorities began their investigation several years ago.

Ara Aprahamian, a former vice president of sales and marketing at Taro, was indicted for working with executives at another drug maker to increase prices and allocate customers for numerous drugs, including medicines used to treat and manage arthritis, seizures, pain, various skin conditions, and blood clots, according to the indictment that was filed in federal court in Philadelphia.

Continue to STAT Plus to read the full story…

Source link

Related posts

Cognitive-focused dev Neuronetrix raises $2m


How to pick the right sunscreen when you're blinded by choice


AI Can Now Diagnose Tumor In Just 2 Minutes


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World